| FOR A 30-DAY SUPPLY: |
|---|
| 1 BOX = 30 single-dose containers (0.2 mL) |
| FOR A 90-DAY SUPPLY: |
|---|
| 3 BOXES = 90 single-dose containers (0.2 mL) |
Thea offers options for home delivery or pickup at a local pharmacy to help ensure that both eye care professionals and patients have an easy way to access IYUZEH™.
Eligible patients pay as little as $60† for a 30-day supply
Pharmacy Name: PhilRx, LLC, Columbus, OH
Type: Retail NPI: 1487463598
Complete this downloadable form and fax to (888) 975-0603
Phone PhilRx at (855) 977-0975, option 1
Patients will receive a link via short text code 744-579 to complete their enrollment and be guided through the complete process.
Patients will automatically receive refill reminders after their first order of IYUZEH.
All patients will receive prescription via free home delivery!
If a prior authorization is required, PhilRx will help support the eye care professional through the process.
*PhilRx is a third-party vendor that administers our patient support program.
Thea offers both a copay and a cash program for those patients who prefer to visit their local pharmacy for their prescriptions.
Eligible patients pay as little as $60† for IYUZEH with the Copay Program.
Step 1: Patients may obtain a card from your office or online, and activate it by visiting MyIYUZEHSavings.com.
Step 2: Patients present an activated Copay Program Card to their pharmacist when picking up their IYUZEH prescription.
‡This program is only for patients who are privately or commercially insured.
Eligible patients pay $75† for IYUZEH with the Cash Program.
Step 1: Patients may obtain a card from your office or online, and activate it by visiting MyIYUZEHSavings.com.
Step 2: Once activated, patients present the Cash Program Card to their pharmacist when picking up a prescription.
Step 3: Some health plans may require notification if an enrolled patient decides to not use their insurance benefits to purchase medication. If applicable, patients using the Cash Program can visit MyIYUZEH.com to download a sample of a Health Plan Notification Letter.
†See full details on terms, conditions, and eligibility requirements for Home Delivery or Local Pharmacy programs.
Order samples for your office.
We are only able to provide samples directly to eye care professionals.
As a pharmacist, it is important to stay up-to-date on wholesaler information. The chart below contains updated information about the leading national wholesalers, allowing you to make informed decisions when selecting the best choice for your pharmacy.
Iris wants to make sure her IOP is lowered by a treatment that is both covered and affordable under her insurance plan. She thought that only meant generics, but learned about IYUZEH and what resources are available to access the medication.
¶Patient portrayal. Not an actual patient.
IYUZEH™ (latanoprost ophthalmic solution) 0.005% is a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Known hypersensitivity to latanoprost or any other ingredients in this product.
IYUZEH may cause changes to pigmented tissues. Most frequently reported changes are increased pigmentation of the iris, periorbital tissue (eyelid), and eyelashes. Pigmentation is expected to increase as long as IYUZEH is administered. Iris pigmentation is likely to be permanent. Eyelid skin darkening and eyelash changes may be reversible.
IYUZEH may cause gradual change to eyelashes including increased length, thickness, and number of lashes. These changes are usually reversible upon discontinuation of treatment.
IYUZEH should be used with caution in patients with a history of intraocular inflammation (iritis/uveitis) and should generally not be used in patients with active intraocular inflammation.
IYUZEH should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema.
Reactivation of herpes simplex keratitis has been reported during treatment with latanoprost. IYUZEH should be used with caution in patients with a history of herpetic keratitis.
Contact lenses should be removed prior to the administration of IYUZEH and may be reinserted 15 minutes after administration.
The most common adverse reactions (5% to 35%) for IYUZEH are: conjunctival hyperemia, eye irritation, eye pruritus, abnormal sensation in eye, foreign body sensation in eyes, vision blurred, and lacrimation increased.
The combined use of two or more prostaglandins or prostaglandin analogs including IYUZEH is not recommended. It has been shown that administration of these prostaglandin drug products more than once daily may decrease the IOP lowering effect or cause paradoxical elevations in IOP.
Please click here for the full Prescribing Information.
